According to Intercept Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 2.50152.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 5.50 | -310.38% |
2021-12-31 | -2.62 | -46.43% |
2020-12-31 | -4.88 | -106.18% |
2019-12-31 | 79.0 | -49.53% |
2018-12-31 | 156 | 74.81% |
2017-12-31 | 89.5 | 945.63% |
2016-12-31 | 8.56 | 41.48% |
2015-12-31 | 6.05 | -58.19% |
2014-12-31 | 14.5 | -9.94% |
2013-12-31 | 16.1 | 87.13% |
2012-12-31 | 8.59 | |
2011-12-31 | N/A |